|
|
|
Stem Cell Related Patent Number US5426098
| Title: | Increase in hematopoietic progenitor cells in peripheral blood by transforming growth factor beta | | Inventors: | Carlino, Joseph A.; San Leandro, CA, USA | | Summary: | Described herein are methods by which the use of transforming growth factor beta (TGF?) increases hematopoietic progenitor cells in peripheral blood. The invention relates to a process by which TGF? is used to increase the number of stem cells in a subject's peripheral blood such that the subject's blood is drawn and the stem cells are removed and readministered to the patient after undergoing myelosuppressive therapy. Further disclosed is an alternate method by which TGF? is administration to a donor subject whose blood is drawn and from whose blood the stem cells are removed and later administered to a separate recipient subject after the recipient subject receives myelosuppressive therapy. Therapeutic application are directed toward the alleviation of side effects in patients undergoing myelosuppressive therapy such as chemotherapy or radiation therapy. | | Abstract: | TGF.beta. is used to increase the numbers of stem cells in a subject's peripheral blood. Then the subject's blood is drawn and the stem cells removed. After myelosuppressive therapy is administered to the subject, the stem cells are administered to the subject. An alternate method provides for TGF.beta. administration to a donor subject whose blood is drawn and from whose blood the stem cells are removed; after a recipient subject receives myelosuppressive therapy, the stem cells are administered to the recipient subject. | | US Patent Website: | Click Here for Full Text of Patent | | Title Number: | US5426098 | | Application Number: | US1993000116253 | | Date Filed: | 02/09/1993 | | Date Published: | 20/06/1995 | | Assignee: | Celtrix Pharmaceuticals, Inc., Santa Clara, CA, USA |
|
|
